The Administrative Core (Core A) is responsible for organizing the program investigators and staff into an effective and well-coordinated team to develop and implement the statistical methods for cancer clinical trials proposed in the research projects to improve the health of cancer patients. This program is integrated across three institutions whith a lead PD/Pl at one institution (UNC-CH) and two additional PD/PIs at the other two institutions (NCSU and Duke). These three PD/PIs form an executive Committee with overall responsibility for the management and administration of the program. Each institution has an additional co-PD/PI to assist the PD/PIs with both the overall and intra-institutional administration of the program project. The Executive Committee, three co-PD/PIs. and individual project leaders form a Steering Committee which provides overall scientific guidance for the program. An External Advisory Committee of experts provides feedback to the Steering Committee on the goals and progress of the program during an annual retreat. Communication and collaboration between project investigators is facilitated with a program project wiki. Communication and dissemination of new results and software are aided with a program project web page. The matrix leadership structure of Core A maximizes the scientific integration of this multi-disciplinary and trans-institutional collaboration.
The Administrative Core (Core A) is essential to the success of the proposed project since it coordinates all administration and provides leadership for the five projects, three cores and three institutions involved in this program project. The administrative component is necessary to facilitate the science of this program project and to achieve the overall program aims, to develop new statistical methods that will improve the health of cancer patients.
|Wang, Xiaofei; Wang, Xiaoyi; Hodgson, Lydia et al. (2017) Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials. Oncologist 22:189-198|
|Zhang, Danjie; Chen, Ming-Hui; Ibrahim, Joseph G et al. (2017) Bayesian Model Assessment in Joint Modeling of Longitudinal and Survival Data with Applications to Cancer Clinical Trials. J Comput Graph Stat 26:121-133|
|Kang, Suhyun; Lu, Wenbin; Song, Rui (2017) Subgroup detection and sample size calculation with proportional hazards regression for survival data. Stat Med 36:4646-4659|
|Zhao, Jingkang; Li, Dongshunyi; Seo, Jungkyun et al. (2017) Quantifying the Impact of Non-coding Variants on Transcription Factor-DNA Binding. Res Comput Mol Biol 10229:336-352|
|Silva, Grace O; Siegel, Marni B; Mose, Lisle E et al. (2017) SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profiling. Genome Biol 18:66|
|Stinchcombe, Thomas E; Zhang, Ying; Vokes, Everett E et al. (2017) Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies. J Clin Oncol 35:2885-2892|
|Li, Zhiguo (2017) Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials. Stat Med 36:403-415|
|Ding, Jieli; Lu, Tsui-Shan; Cai, Jianwen et al. (2017) Recent progresses in outcome-dependent sampling with failure time data. Lifetime Data Anal 23:57-82|
|Liang, Baosheng; Tong, Xingwei; Zeng, Donglin et al. (2017) SEMIPARAMETRIC REGRESSION ANALYSIS OF REPEATED CURRENT STATUS DATA. Stat Sin 27:1079-1100|
|Kong, Dehan; Maity, Arnab; Hsu, Fang-Chi et al. (2017) Rejoinder to ""A note on testing and estimation in marker-set association study using semiparametric quantile regression kernel machine"". Biometrics :|
Showing the most recent 10 out of 462 publications